Morgan Stanley, Leerink, Cantor Fitzgerald and Stifel acted as joint book running managers for the offering.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRVI:
- Closing Bell Movers: Netflix down 9% as Q2 outlook misses, Hastings leaves board
- Trevi Therapeutics announces $150M common stock offering
- Trevi Therapeutics: Positive Needham Conference Takeaways Reinforce Buy Rating and Favorable Risk‑Reward Profile
- Trevi Therapeutics price target lowered to $24 from $25 at JonesResearch
- Trevi Therapeutics Maps Phase III Path and Runway